The orthopedic device company pulled the product after evidence showed higher revision rates at five and seven years compared to rival products.
More Articles on Orthopedic Devices:
NeuroMetrix Signs Distribution Agreement for Pain Management Device
ConforMIS Moves Corporate Headquarters
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.